New Petition Targets Dartmouth Patent Covering ‘Isolated’ Nicotinamide

(February 2, 2021, 1:59 PM EST) -- ALEXANDRIA, Va. — A research organization on Feb. 1 told the Patent Trial and Appeal Board that it should cancel a patent that recites isolated nicotinamide riboside kinase (Nrk) nucleic acid...
To view the full article, register now.